Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 67877-443
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 67877-443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Rabe-30-count (Rabe 30 Count)
Each Delayed-Release tablet contains 20 mg of Rabeprazole Sodium. The medication is to be stored between 25°C to 30°C (59°F to 86°F) and protected from moisture. Dispense in tight containers. This medicine is manufactured by Akem Laboratories and distributed by Ascend Laboratories. The prescribing information should be referred to for dosage and use. The medication guide should be dispensed to each patient.*
Rabe-str (Rabe Str)
Rabe-str2 (Rabe Str2)
Rabe-str3 (Rabe Str3)
The text provides data on the mean score for heartburn for a study comparing a placebo group and a group taking 20mg of Rab. The study involved 58 individuals in the placebo group and 59 individuals in the Rab group. The heartburn scores ranged from 0 (none) to 4 (very severe), and the scores were recorded on study days 0, 7, 14, 21, and 28.*
Rabe-str4 (Rabe Str4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.